Thermopylae Holdings Ltd. bought ABCL
November 12, 2026 · Form 4 insider transaction
Thermopylae Holdings Ltd. bought 60,565 shares of AbCellera Biologics Inc. at $11.54 per share, a transaction worth $698.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
60,565
Price
$11.54
Total value
$698.9K
InsiderThermopylae Holdings Ltd.
Role—
SecurityCommon Shares
Transaction codeP: Open-market purchase
Transaction dateNovember 12, 2026
Filing dateNovember 12, 2026
Shares owned after56,194,662
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $11.29 to $11.86. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.